Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
ListGraphMap
Displaying 1 - 10 of 15 Projects
Project # Contact PI Funding Organization Fiscal Year
Discovery of selective LRP1 inhibitors to prevent tau uptake and spread
ADDF-57 Kosik, Kenneth Alzheimer's Drug Discovery Foundation 2022
Repairing neurotransmission in Alzheimer's disease and related disorders by targeting caspase-2
ADDF-58 Ashe, Karen Alzheimer's Drug Discovery Foundation 2022
FINGERS Brain Health Institute
ADDF-59 Kivipelto, Miia Alzheimer's Drug Discovery Foundation 2022
A single-center, randomized, placebo-controlled single & multiple ascending dose study in healthy subjects to study the safety, tolerability, food effect, pharmacokinetics and target engagement of the second-generation O-GlcNAcase inhibitor ASN121151
ADDF-1 Beher, Dirk Alzheimer's Drug Discovery Foundation 2020
AFTD Patient-Focused Drug Development Meeting with the FDA
ADDF-10 Dickinson, Susan Alzheimer's Drug Discovery Foundation 2020
A Placebo Controlled, Randomized Double-blind Parallel Group 12-month Trial of Fasudil for the Treatment of Mild Cognitive Impairment Due to Alzheimer's disease, nested within a Multi-Arm Phase 2 Clinical Trial Platform
ADDF-13 Ballard, Clive Alzheimer's Drug Discovery Foundation 2020
MET-FINGER-APOE: A randomized controlled trial of multimodal lifestyle intervention and metformin to prevent cognitive impairment and disability in a cognitively healthy APOE4 enriched at-risk population
ADDF-14 Kivipelto, Miia Alzheimer's Drug Discovery Foundation 2020
Development of a PIKFYVE antisense oligonucleotide (ASO) treatment for FTD
ADDF-2 Chang, Wen-Hsuan Alzheimer's Drug Discovery Foundation 2020
Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease
ADDF-25 Orr, Miranda Alzheimer's Drug Discovery Foundation 2020
Phase I Clinical Trial for the AAV mediated treatment of APOE4 homozygous Alzheimer's Disease
ADDF-26 Crystal, Ronald Alzheimer's Drug Discovery Foundation 2020